KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $42,000 | -78.2% | 12,660 | -75.2% | 0.00% | – |
Q2 2018 | $193,000 | -80.5% | 51,071 | -78.9% | 0.00% | – |
Q1 2018 | $990,000 | +254.8% | 242,200 | +302.3% | 0.00% | – |
Q4 2017 | $279,000 | +11.2% | 60,200 | +70.1% | 0.00% | – |
Q3 2017 | $251,000 | -50.7% | 35,382 | -49.8% | 0.00% | – |
Q2 2017 | $509,000 | +17.3% | 70,467 | 0.0% | 0.00% | – |
Q1 2017 | $434,000 | +1636.0% | 70,467 | +1254.4% | 0.00% | – |
Q1 2016 | $25,000 | -13.8% | 5,203 | -5.8% | 0.00% | – |
Q4 2015 | $29,000 | -78.2% | 5,522 | -85.3% | 0.00% | – |
Q3 2015 | $133,000 | +6550.0% | 37,558 | +18679.0% | 0.00% | – |
Q2 2015 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q1 2015 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2014 | $3,000 | -91.9% | 200 | -91.8% | 0.00% | – |
Q2 2014 | $37,000 | +1133.3% | 2,430 | +1115.0% | 0.00% | – |
Q1 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2013 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q3 2013 | $2,000 | 0.0% | 200 | -20.0% | 0.00% | – |
Q2 2013 | $2,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |